These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1627026)

  • 1. Cost and quality effects of alternative treatments for persistent gastroesophageal reflux disease.
    Hillman AL; Bloom BS; Fendrick AM; Schwartz JS
    Arch Intern Med; 1992 Jul; 152(7):1467-72. PubMed ID: 1627026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic analysis of alternative treatments for persistent gastro-oesophageal reflux disease.
    Hillman AL
    Scand J Gastroenterol Suppl; 1994; 201():98-102. PubMed ID: 8047833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of life during acute and intermittent treatment of gastro-oesophageal reflux disease with omeprazole compared with ranitidine. Results from a multicentre clinical trial. The European Study Group.
    Wiklund I; Bardhan KD; Müller-Lissner S; Bigard MA; Bianchi Porro G; Ponce J; Hosie J; Scott M; Weir D; Fulton C; Gillon K; Peacock R
    Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):19-27. PubMed ID: 9615259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Empiric therapy for gastroesophageal reflux disease.
    Schindlbeck NE; Klauser AG; Voderholzer WA; Müller-Lissner SA
    Arch Intern Med; 1995 Sep; 155(16):1808-12. PubMed ID: 7654116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Omeprazole versus high-dose ranitidine in mild gastroesophageal reflux disease: short- and long-term treatment. The Dutch Reflux Study Group.
    Festen HP; Schenk E; Tan G; Snel P; Nelis F
    Am J Gastroenterol; 1999 Apr; 94(4):931-6. PubMed ID: 10201459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness and costs of omeprazole vs ranitidine for treatment of symptomatic gastroesophageal reflux disease in primary care clinics in West Virginia.
    Kaplan-Machlis B; Spiegler GE; Zodet MW; Revicki DA
    Arch Fam Med; 2000 Jul; 9(7):624-30. PubMed ID: 10910310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Drug therapy of gastroesophageal reflux (a prospective controlled clinical trial)].
    Wittmann T; Rosztóczy A; Fehér A; Jármay K; Oláh T; Szendrényi V; Kiss I
    Orv Hetil; 1998 May; 139(18):1077-81. PubMed ID: 9608770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Omeprazole versus ranitidine or ranitidine/metoclopramide in poorly responsive symptomatic gastroesophageal reflux disease.
    Richter JE; Sabesin SM; Kogut DG; Kerr RM; Wruble LD; Collen MJ
    Am J Gastroenterol; 1996 Sep; 91(9):1766-72. PubMed ID: 8792695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical trial: the effects of adding ranitidine at night to twice daily omeprazole therapy on nocturnal acid breakthrough and acid reflux in patients with systemic sclerosis--a randomized controlled, cross-over trial.
    Janiak P; Thumshirn M; Menne D; Fox M; Halim S; Fried M; Brühlmann P; Distler O; Schwizer W
    Aliment Pharmacol Ther; 2007 Nov; 26(9):1259-65. PubMed ID: 17944740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost effectiveness of omeprazole and ranitidine in intermittent treatment of symptomatic gastro-oesophageal reflux disease.
    Stålhammar NO; Carlsson J; Peacock R; Müller-Lissner S; Bigard MA; Porro GB; Ponce J; Hosie J; Scott M; Weir DG; Fulton C; Gillon K; Bardhan KD
    Pharmacoeconomics; 1999 Nov; 16(5 Pt 1):483-97. PubMed ID: 10662395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children.
    Canani RB; Cirillo P; Roggero P; Romano C; Malamisura B; Terrin G; Passariello A; Manguso F; Morelli L; Guarino A;
    Pediatrics; 2006 May; 117(5):e817-20. PubMed ID: 16651285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton pump inhibitors or histamine-2 receptor antagonists for the prevention of recurrences of erosive reflux esophagitis: a cost-effectiveness analysis.
    Harris RA; Kuppermann M; Richter JE
    Am J Gastroenterol; 1997 Dec; 92(12):2179-87. PubMed ID: 9399748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re-examination of the cost-effectiveness of surgical versus medical therapy in patients with gastroesophageal reflux disease: the value of long-term data collection.
    Arguedas MR; Heudebert GR; Klapow JC; Centor RM; Eloubeidi MA; Wilcox CM; Spechler SJ;
    Am J Gastroenterol; 2004 Jun; 99(6):1023-8. PubMed ID: 15180720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of patient satisfaction with a formulary switch from omeprazole to lansoprazole in gastroesophageal reflux disease maintenance therapy.
    Condra LJ; Morreale AP; Stolley SN; Marcus D
    Am J Manag Care; 1999 May; 5(5):631-8. PubMed ID: 10537869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective evaluation of esophageal testing and a double-blind, randomized study of omeprazole in a diagnostic and therapeutic algorithm for chronic cough.
    Ours TM; Kavuru MS; Schilz RJ; Richter JE
    Am J Gastroenterol; 1999 Nov; 94(11):3131-8. PubMed ID: 10566703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical effectiveness and quality of life with ranitidine vs placebo in gastroesophageal reflux disease patients: a clinical experience network (CEN) study.
    Rush DR; Stelmach WJ; Young TL; Kirchdoerfer LJ; Scott-Lennox J; Holverson HE; Sabesin SM; Nicholas TA
    J Fam Pract; 1995 Aug; 41(2):126-36. PubMed ID: 7636452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized trial comparing omeprazole, ranitidine, cisapride, or placebo in helicobacter pylori negative, primary care patients with dyspepsia: the CADET-HN Study.
    Veldhuyzen van Zanten SJ; Chiba N; Armstrong D; Barkun A; Thomson A; Smyth S; Escobedo S; Lee J; Sinclair P
    Am J Gastroenterol; 2005 Jul; 100(7):1477-88. PubMed ID: 15984968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cost-effectiveness analysis of prescribing strategies in the management of gastroesophageal reflux disease.
    Gerson LB; Robbins AS; Garber A; Hornberger J; Triadafilopoulos G
    Am J Gastroenterol; 2000 Feb; 95(2):395-407. PubMed ID: 10685741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maintenance therapy for erosive esophagitis in children after healing by omeprazole: is it advisable?
    Boccia G; Manguso F; Miele E; Buonavolontà R; Staiano A
    Am J Gastroenterol; 2007 Jun; 102(6):1291-7. PubMed ID: 17319927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic therapy of Helicobacter pylori infection reduces healthcare expenditures related to duodenal ulcer.
    Sonnenberg A; Pauly MP; Levenson SD; Schwartz JS
    Am J Manag Care; 1999 Jan; 5(1):53-9. PubMed ID: 10345967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.